PB1847: ACUTE MYELOID LEUKEMIA – IS IT MORE BESIDES GENETIC ABNORMALITIES?

por Urbano, M., Marques, B., Peixinho, M., Sousa, R., Nora, C., Almeida, C., Silva, D., Moura, P., Marini, S., Silva, N., Roque, A., Cortesão, E., Geraldes, C.
Publicado 2022

P27: HUMORAL RESPONSE RATE POST MRNA COVID19 VACCINATION (BNT162B2) IS HIGLY DEPENDENT TO BONE MARROW PLASMACYTOSIS: LONG FOLLOW-UP OF SYMPTOMATIC MULTIPLE MYELOMA PATIENTS

por Mele, G, Romano, C, Spina, A, Merchionne, F, Quintana, G, Urbano, M, Pasanisi, AM, Rinaldi, E, Solfrizzi, MP, Romano, A, Guaragna, G, DiNoi, ML, Miccoli, A, Santoro, A, Pastore, D
Publicado 2022

A phase II trial of induction chemotherapy and chemo-IMRT for head and neck squamous cell cancers at risk of bilateral nodal spread: the application of a bilateral superficial lobe...

por Miah, A B, Schick, U, Bhide, S A, Guerrero-Urbano, M-T, Clark, C H, Bidmead, A M, Bodla, S, Del Rosario, L, Thway, K, Wilson, P, Newbold, K L, Harrington, K J, Nutting, C M
Publicado 2015

Modified CHA2DS2-VASc can predict mortality in COVID-19 patients admitted to the emergency department

por Silva, B V, Jorge, C, Mendonca, C, Urbano, M L, Rodrigues, T, Silverio Antonio, P, Brito, J, Alves Da Silva, P, Garcia, B, Martins, C, Rigueira, J, Ricardo Aguiar, I, Nobre Menezes, M, Placido, R, J Pinto, F
Publicado 2021